8-K ·Filed Sep 4, 2026

AZTA

Azenta, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed28d 9h ago SEC0001628280-26-060614
8-K context-dependent: Items 7.01, 8.01
Actionable Insight • Neutral

This filing completes the cash collection from the B Medical Systems divestiture. Monitor Azenta's capital allocation plans now that the full $63M is in cash, but no immediate trading catalyst is evident from this routine event.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
AZTA ▲ +2.27% at T+5d
NEUTRAL call ✓ call won +2.27% · α vs SPY +3.48% · entry $31.33 → $32.04
Next anchor: T+20d in 3d
Latest observation: T+16 +11.04% FF3 residual α
Entry anchored
Sep 4, 07:45 AM ET
via 1-min bar
T+1d
-1.63%
call -1.63% · α -1.08%
$30.82
settled 24d ago
T+5d
+2.27%
call +2.27% · α +3.48%
$32.04
settled 18d ago
T+20d
—
call — · α —
—
in 3d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Azenta announced the full repayment of a $35 million secured vendor loan from Thelema S.à r.l., which was extended as part of the sale of B Medical Systems. The loan was repaid early with all accrued interest ($35,373,333 total), completing the cash collection of the $63 million purchase price and eliminating the associated credit exposure.

Key Facts

  • Vendor loan of $35,000,000 repaid in full prior to maturity on September 3, 2026
  • Total repayment amount including accrued interest was $35,373,333
  • Entire $63,000,000 purchase price for B Medical Systems has now been received in cash
  • The share pledge securing the loan has been released
  • Transaction completes the divestiture of B Medical Systems

Financial Impact

Azenta received $35,373,333 in cash from the vendor loan repayment, bringing total cash proceeds from the B Medical Systems sale to $63,000,000.

cashcredit exposure

Risk Factors

  • None directly; this is a positive resolution of a previously disclosed credit exposure.

Market Snapshot

Exchange
Nasdaq
Sector
Special Industry Machinery, NEC
Analyst Consensus
69% bullish (13 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-060614
Document: aztaprbmedicalloanrepaym.htm0001628280-26-060614
Document: 0001628280-26-060614-index-headers.html0001628280-26-060614
Document: 0001628280-26-060614-index.html0001628280-26-060614
Document: 0001628280-26-060614.txt0001628280-26-060614
7 reports for AZTA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AZTA — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
8-K
NEUTRAL ★ 4/10
$31.33 $32.04▲ +2.27%▲ +3.48%$38.75 (+23.68%)
Aug 24, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$32.88 $32.65▼ −0.70%▼ −1.17%$38.75 (+17.85%)
Aug 8, 2026
7w ago
Institutional Cluster
MIXED ★ 5/10
$33.33 $33.58▲ +0.75%▲ +0.80%$38.75 (+16.26%)
Aug 4, 2026
8w ago
Press Release
BULLISH ★ 7/10
$31.82 $33.53▲ +5.37%▲ +5.02%$38.75 (+21.78%)
Jul 8, 2026
12w ago
8-K
MIXED ★ 5/10
$24.51 $25.44▲ +3.79%▲ +2.93%$38.75 (+58.10%)
May 5, 2026
21w ago
8-K
BEARISH ★ 8/10
$18.38 $17.53▲ +4.62%▲ +5.76%$38.75 (−110.83%)
Apr 7, 2026
25w ago
8-K
NEUTRAL ★ 6/10
$21.71 $24.26▲ +11.75%▲ +6.42%$38.75 (+78.49%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (38h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access